| (Values in U.S. Thousands) | Dec, 2019 | Dec, 2018 | Dec, 2017 | Dec, 2016 | Dec, 2015 |
| Sales | 40,090 | 30,650 | 17,270 | 9,620 | 0 |
| Sales Growth | +30.80% | +77.48% | +79.52% | unch | unch |
| Net Income | -6,640 | 340 | 5,310 | 960 | -680 |
| Net Income Growth | -2,052.94% | -93.60% | +453.13% | +241.18% | -9.68% |
Kiwa Bio-Tech Products Group Corp (KWBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Kiwa Bio-Tech Products Group Corporation develops, manufactures, distributes and markets innovative, cost-effective, and environmentally safe bio-technological products for agricultural and natural resources and environmental conservation. The Company's products are designed to enhance the quality of human life by increasing the value, quality and productivity of crops and decreasing the negative environmental impact of chemicals and other wastes. It also develops a veterinary drug based on AF-01 anti-viral aerosol technology, an antiviral agent with potent inhibitory and/or viricidal effects on RNA viruses found in animals and fowls. In addition, Kiwa Bio-Tech Products Group, through its joint venture with Tianjin Challenge Feed Co., Ltd., develops, manufactures, and markets bio-feed products for livestock. It also has joint venture with Hebei Huaxing Pharmaceuticals Co., Ltd that develops, manufactures, and markets animal drugs and disinfectants, including AF-01 anti-viral aerosol technology-based products.
Fiscal Year End Date: 12/31